Abstract
We hypothesised that the measurement of circulating collagen-degrading matrix metalloproteinases (MMPs) would be predictive of postsurgical outcome after fasciectomy for Dupuytren disease (DD), measured through total extension deficit (TED). Assay of MMP-1, MMP-13 and MMP-14 in the plasma of DD patients showed poor correlation with change in TED after surgery. However, MMP-14 levels correlated with preoperative TED. In order to extend this study, we also measured the transcriptome in tissue samples from DD patients and showed that expression of specific genes correlated with preoperative and postoperative TED. These methodologies demonstrate the use of the approach in uncovering biomarkers which both illuminate the mechanism of the disease and have clinical utility.
Keywords
- Gene expression
- qRT-PCR
- ELISA
- Microarray
- Biomarker
- Recurrence
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bisson MA et al (2004) The contractile properties and responses to tensional loading of Dupuytren’s disease-derived fibroblasts are altered: a cause of the contracture? Plast Reconstr Surg 113:611–621
Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803:55–71
Daniels JT et al (2003) Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci 44:1104–1110
Dolmans GH et al (2011) Wnt signaling and Dupuytren’s disease. N Engl J Med 365:307–317
Hutchinson JW et al (1998) Dupuytren’s disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor. J Bone Joint Surg Br 80:907–908
Itoh Y (2015) Membrane-type matrix metalloproteinases: their functions and regulations. Matrix Biol 44–46:207–223
Johnston P et al (2007) A complete expression profile of matrix-degrading metalloproteinases in Dupuytren’s disease. J Hand Surg Am 32:343–351
Johnston P et al (2008) Metalloproteinase gene expression correlates with clinical outcome in Dupuytren’s disease. J Hand Surg Am 33:1160–1167
Kelwick R et al (2015) The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol 16:113
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67
Raykha C et al (2013) IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren’s disease. Biochim Biophys Acta 1832:1511–1519
Shaw RB et al (2007) Dupuytren’s disease: history, diagnosis, and treatment. Plast Reconstr Surg 120:44e–54e
Shih B et al (2012a) DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren’s disease: potential role for MMP and Wnt signaling pathway. Plast Reconstr Surg 129:921–932
Shih B et al (2012b) Whole genome and global expression profiling of Dupuytren’s disease: systematic review of current findings and future perspectives. Ann Rheum Dis 71:1440–1447
Townley WA et al (2006) Dupuytren’s contracture unfolded. BMJ 332:397–400
Townley WA et al (2008) Matrix metalloproteinase inhibition reduces contraction by dupuytren fibroblasts. J Hand Surg 33:1608–1616
Ulrich D, Hrynyschyn K, Pallua N (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinase in sera and tissue of patients with Dupuytren’s disease. Plast Reconstr Surg 112:1279–1286
Vandenbroucke RE, Libert C (2014) Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov 13:904–927
Wilkinson JM et al (2012) MMP-14 and MMP-2 are key metalloproteases in Dupuytren’s disease fibroblast-mediated contraction. Biochim Biophys Acta 1822:897–905
Acknowledgements and Conflicts of Interest
This study was funded by a grant from Medical Technologies Innovation and Knowledge Centre, University of Leeds, UK (POC Tranche 2 RG.MECH.101434). – The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jupp, O., Pullinger, M., Marjoram, T., Lott, M., Chojnowski, A.J., Clark, I.M. (2017). Biomarkers of Postsurgical Outcome in Dupuytren Disease. In: Werker, P., Dias, J., Eaton, C., Reichert, B., Wach, W. (eds) Dupuytren Disease and Related Diseases - The Cutting Edge. Springer, Cham. https://doi.org/10.1007/978-3-319-32199-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-32199-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32197-4
Online ISBN: 978-3-319-32199-8
eBook Packages: MedicineMedicine (R0)